Article Versions Notes

Fermaintt CS, Peramuna T, Cai S, Takahashi-Ruiz L, Essif JN, Grant CV, O’Keefe BR, Mooberry SL, Cichewicz RH, Risinger AL. Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential. Cancers. 2021; 13(11):2834. https://doi.org/10.3390/cancers13112834

Fermaintt, Charles S., Thilini Peramuna, Shengxin Cai, Leila Takahashi-Ruiz, Jacob Nathaniel Essif, Corena V. Grant, Barry R. O’Keefe, Susan L. Mooberry, Robert H. Cichewicz, and April L. Risinger. 2021. "Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential" Cancers 13, no. 11: 2834. https://doi.org/10.3390/cancers13112834

Fermaintt, C. S., Peramuna, T., Cai, S., Takahashi-Ruiz, L., Essif, J. N., Grant, C. V., O’Keefe, B. R., Mooberry, S. L., Cichewicz, R. H., & Risinger, A. L. (2021). Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential. Cancers, 13(11), 2834. https://doi.org/10.3390/cancers13112834